| (i) Name of supported organization | (ii) EIN | (iii) Type of organization (described on lines 1- 10 above (see instructions)) | (iv) Is the organization listed in your governing document? | (v) Amount of monetary support (see instructions) | (vi) Amount of other support (see instructions) | |
|---|---|---|---|---|---|---|
| Yes | No | |||||
|
Total |
||||||
| Calendar year (or fiscal year beginning in) | (a) 2021 | (b) 2022 | (c) 2023 | (d) 2024 | (e) 2025 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grant.") .. | 500 | 7,218 | 126,504 | 348,685 | 482,907 | |
| 2 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf .... | 0 | |||||
| 3 | The value of services or facilities furnished by a governmental unit to the organization without charge.. | 0 | |||||
| 4 | Total. Add lines 1 through 3 | 500 | 7,218 | 126,504 | 348,685 | 482,907 | |
| 5 | The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f) .. | 0 | |||||
| 6 | Public support. Subtract line 5 from line 4. | 482,907 | |||||
| Calendar year (or fiscal year beginning in) | (a) 2021 | (b) 2022 | (c) 2023 | (d) 2024 | (e) 2025 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 7 | Amounts from line 4.. | 500 | 7,218 | 126,504 | 348,685 | 482,907 | |
| 8 | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources... | 2,802 | 2,802 | ||||
| 9 | Net income from unrelated business activities, whether or not the business is regularly carried on.. | ||||||
| 10 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.).. | 0 | |||||
| 11 | Total support. Add lines 7 through 10 | 485,709 | |||||
| Calendar year (or fiscal year beginning in) | (a) 2021 | (b) 2022 | (c) 2023 | (d) 2024 | (e) 2025 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") | ||||||
| 2 | Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose | ||||||
| 3 | Gross receipts from activities that are not an unrelated trade or business under section 513 ..... | ||||||
| 4 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf... | ||||||
| 5 | The value of services or facilities furnished by a governmental unit to the organization without charge | ||||||
| 6 | Total. Add lines 1 through 5 | ||||||
| 7a | Amounts included on lines 1, 2, and 3 received from disqualified persons | ||||||
| b | Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year. | ||||||
| c | Add lines 7a and 7b.. | ||||||
| 8 | Public support. (Subtract line 7c from line 6.) | ||||||
| Calendar year (or fiscal year beginning in) | (a) 2021 | (b) 2022 | (c) 2023 | (d) 2024 | (e) 2025 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 9 | Amounts from line 6 | ||||||
| 10a | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources | ||||||
| b | Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975 | ||||||
| c | Add lines 10a and 10b | ||||||
| 11 | Net income from unrelated business activities not included on line 10b, whether or not the business is regularly carried on. | ||||||
| 12 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.) .. | ||||||
| 13 | Total support. (Add lines 9, 10c, 11, and 12.).. | ||||||
| Section A - Adjusted Net Income | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Net short-term capital gain | 1 | ||||
| 2 | Recoveries of prior-year distributions | 2 | ||||
| 3 | Other gross income (see instructions) | 3 | ||||
| 4 | Add lines 1 through 3 | 4 | ||||
| 5 | Depreciation and depletion | 5 | ||||
| 6 | Portion of operating expenses paid or incurred for production or collection of gross income or for management, conservation, or maintenance of property held for production of income (see instructions) | 6 | ||||
| 7 | Other expenses (see instructions) | 7 | ||||
| 8 | Adjusted Net Income (subtract lines 5, 6 and 7 from line 4) | 8 | ||||
| Section B - Minimum Asset Amount | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Aggregate fair market value of all non-exempt-use assets (see instructions for short tax year or assets held for part of year): | 1 | ||||
| a | Average monthly value of securities | 1a | ||||
| b | Average monthly cash balances | 1b | ||||
| c | Fair market value of other non-exempt-use assets | 1c | ||||
| d | Total (add lines 1a, 1b, and 1c) | 1d | ||||
| e |
Discount claimed for blockage or other factors (explain in detail in Part VI): |
|||||
| 2 | Acquisition indebtedness applicable to non-exempt use assets | 2 | ||||
| 3 | Subtract line 2 from line 1d | 3 | ||||
| 4 | Cash deemed held for exempt use. Enter 0.015 of line 3 (for greater amount, see instructions). | 4 | ||||
| 5 | Net value of non-exempt-use assets (subtract line 4 from line 3) | 5 | ||||
| 6 | Multiply line 5 by 0.035 | 6 | ||||
| 7 | Recoveries of prior-year distributions | 7 | ||||
| 8 | Minimum Asset Amount (add line 7 to line 6) | 8 | ||||
| Section C - Distributable Amount | Current Year | |||||
| 1 | Adjusted net income for prior year (from Section A, line 8, Column A) | 1 | ||||
| 2 | Enter 85% of line 1 | 2 | ||||
| 3 | Minimum asset amount for prior year (from Section B, line 8, Column A) | 3 | ||||
| 4 | Enter greater of line 2 or line 3 | 4 | ||||
| 5 | Income tax imposed in prior year | 5 | ||||
| 6 | Distributable Amount. Subtract line 5 from line 4, unless subject to emergency temporary reduction (see instructions) | 6 | ||||
| Section D - Distributions | Current Year | |
|---|---|---|
| 1 Amounts paid to supported organizations to accomplish exempt purposes | 1 | |
|
2
Amounts paid to perform activity that directly furthers exempt purposes of supported organizations, in excess of income from activity |
2 | |
| 3 Administrative expenses paid to accomplish exempt purposes of supported organizations | 3 | |
| 4 Amounts paid to acquire exempt-use assets | 4 | |
| 5 Qualified set-aside amounts (prior IRS approval required - provide details in Part VI) | 5 | |
| 6Total annual distributions. Add lines 1 through 5. | 6 | |
|
7
Distributions to attentive supported organizations to which the organization is responsive (provide details in Part VI). See instructions |
7 | |
| 8 Distributable amount for 2025 from Section C, line 6 | 8 | |
| 9 Line 7 amount divided by Line 8 amount | 9 | |
| Section E - Distribution Allocations (see instructions) |
(i) Excess Distributions |
(ii) Underdistributions Pre-2025 |
(iii) Distributable Amount for 2025 |
|
|---|---|---|---|---|
| 1 Distributable amount for 2025 from Section C, line 6 | ||||
|
2
Underdistributions, if any, for years prior to 2025 (reasonable cause required-- explain in Part VI).
See instructions. |
||||
| 3 Excess distributions carryover, if any, to 2025: | ||||
| a From 2020....... | ||||
| b From 2021....... | ||||
| c From 2022....... | ||||
| d From 2023....... | ||||
| e From 2024....... | ||||
| fTotal of lines 3a through e | ||||
| g Applied to underdistributions of prior years | ||||
| h Applied to 2025 distributable amount | ||||
|
i
Carryover from 2020 not applied (see instructions) |
||||
| j Remainder. Subtract lines 3g, 3h, and 3i from line 3f. | ||||
| 4Distributions for 2025 from Section D, line 6: | ||||
| $ | ||||
| a Applied to underdistributions of prior years | ||||
| b Applied to 2025 distributable amount | ||||
| c Remainder. Subtract lines 4a and 4b from line 4. | ||||
|
5
Remaining underdistributions for years prior to 2025, if any. Subtract lines 3g and 4a from line 2. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
6
Remaining underdistributions for 2025. Subtract lines 3h and 4b from line 1. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
7 Excess distributions carryover to 2026. Add lines 3j and 4c. |
||||
| 8 Breakdown of line 7: | ||||
| a Excess from 2021..... | ||||
| b Excess from 2022..... | ||||
| c Excess from 2023..... | ||||
| d Excess from 2024..... | ||||
| e Excess from 2025..... | ||||
| Facts And Circumstances Test |
|---|
| Return Reference | Explanation |
|---|
| Software ID: | 25022934 |
| Software Version: | 2025v4.1 |
| Return Reference | Explanation |
|---|---|
| Form 990, Part VI, Section B, Line 11b | The board receives a copy of the 990 prior to its filing with the IRS. |
| Form 990, Part VI, Section B, Line 15a | An annual survey of similar organizations of a similar size is completed to inform the board of current market rates for the CEO position. The full board reviews and votes on the CEO compensation. |
| Form 990, Part VI, Section C, Line 19 | ERDC's governing documents, conflict of interest policy, and financial statements are available upon request. |
| HEAT Kits | HEAT Kits are Hospital Emergency Advocacy and Treatment KitsA person with GPA, MPA, EGPA, MG, lgG4-RD, or HES generally does not get to what they need when a flare sends them to the emergency room. Too often, the clinicians have never treated their condition. It would be unreasonable to think they had. The conditions are rare and treatments are scarce.Additionally, these diseases are often existing way below the skin and the patient shows for care "looking fine and with standard labs appearing normal and fine. When they are anything but fine. The sick person in the bed or the loved one that comes with them becomes the only expert in the room.The HEAT Kit exists to change that moment. It puts plain-language, disease-specific information directly into the hands of our community and the emergency teams treating them, so a crisis does not turn into a battle for basic recognition. We build this resource in print form so as to be accessible to providers and emergency responders without navigating a phone. The professional quality provides the patient confidence and translates to credibility when being given to providers to reference. HEAT Kits are disease specific, have been reviewed by experts in the field and are designed to be useful in the ER, hospital and any medical setting. |
| Public Policy | Rare disease does not stay out of politics, because access to treatment is decided in policy long before it is decided in a doctor's office. ERDC shows up where those decisions get made. We speak directly to legislators and regulators on the issues that determine whether our community can afford and access the treatments keeping them alive, from opposing the withdrawal of essential medications to pushing back on drug pricing frameworks that leave 95 percent of rare diseases unprotected because they lack an approved treatment. We have submitted formal comment letters, briefed congressional staff, and organized alongside national partners because the people most affected by these policies are rarely in the room when they are written. We put them there. This work is not partisan. It is about what our community needs, said plainly and said directly. |
| Rare Candor Podcast | Rare disease conversations are too often sanitized, softened, or skipped entirely. Rare Candor exists because our community deserves the opposite: honest conversations about what it actually means to live with GPA, MPA, EGPA, MG, lgG4-RD, or HES, and to care for someone who does. Each episode brings real people, real clinicians, and real advocates into a conversation without a script. This is raw and real storytelling as advocacy, proof that the most powerful education comes from people telling the truth about their own lives. This podcast is available on Spotify and Apple platforms. |
| The ANCA Vasculitis Decision Tree | When someone with GPA, MPA, or EGPA is in front of a clinician who has never managed their condition, every minute spent explaining the basics is a minute not spent on treatment. The ANCA Vasculitis Decision Tree gives providers and people with the disease a clear, visual path through diagnosis and emergency decision-making, built from the patterns our community has lived through again and again. The platform is a step by step tool that walks people through their personalized path and provides them with print outs throughout the Decision Tree journey. It is grounded in a formal white paper written for journal submission, so the tool carries clinical weight, not just community insight. This is what it looks like when people with rare disease stop waiting for research to catch up and start writing it themselves. |
| The Biologics Livestream Seris | ERDC Livestreams brings people face to face with the information they need to make that leap with confidence, not guesswork when accessing their treatment, understanding the nuances of treatment decisions and navigating insurance. We partner directly with pharmacists, experts and the companies developing these treatments to answer real questions from our community in real time, no jargon, no runaround. This is education built on trust, delivered by an organization that answers to the people watching, not to a marketing calendar, and are enduring material on our YouTube platform. |
| Who We Serve | Somewhere tonight, a person will sit in an emergency room and try to explain a disease most doctors have never heard of, meet with a new doctor that has never treated their rare disease, or try to access their medication only to be denied. That moment is why ERDC exists.We serve people living with Granulomatosis with Polyangiitis (GPA), Microscopic Polyangiitis (MPA), Eosinophilic Granulomatosis with Polyangiitis (EGPA), Myasthenia Gravis (MG), lgG4-Related Disease (lgG4-RD), and Hypereosinophilic Syndrome (HES). These are conditions most people have never heard of, diagnosed too late, treated with too little urgency, and researched with too little funding.ERDC is a patient- and care partner-run organization, which means every program we build comes from people who have lived through the diagnosis, the treatment, and the fight for care that meets them where they are.We are not chasing a cure. We are working for access to the right treatment at the right time, every time. The patient communities we engage with reaches more than 120,000 people, and it keeps growing because the need does not go away when the awareness campaign ends. |
| Software ID: | 25022934 |
| Software Version: | 2025v4.1 |